Forodesine – Preclinical Studies


Published: June 10, 2009
Abstract Views: 132
PDF: 534
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Chemically forodesine is [(1S)-1-(9-deazahypoxanthin-9-yl)-1,4-dideoxy-1,4-imino-D-ribitol]. The agent is also known as immucillin hypoxanthine (immucillin H) or BCX-1777. This is a potent inhibitor of the enzyme purine nucleoside phosphorylase (PNP).

Supporting Agencies


Gandhi, V. (2009). Forodesine – Preclinical Studies. Hematology Meeting Reports (formerly Haematologica Reports), 2(13). https://doi.org/10.4081/hmr.v2i13.484

Downloads

Citations